DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Motzer RJ, Tannier NM, McDermott DF. et al.
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
(akzeptiert für NEJM)
We do not assume any responsibility for the contents of the web pages of other providers.